0001698261-17-000001.txt : 20170309 0001698261-17-000001.hdr.sgml : 20170309 20170309151049 ACCESSION NUMBER: 0001698261-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 EFFECTIVENESS DATE: 20170309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOPHARM PHARMACANN INVESTORS II, LLC CENTRAL INDEX KEY: 0001698261 IRS NUMBER: 814985333 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-282173 FILM NUMBER: 17678070 BUSINESS ADDRESS: STREET 1: 300 SOUTH WACKER DRIVE STREET 2: STE 2750 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-444-6361 MAIL ADDRESS: STREET 1: 300 SOUTH WACKER DRIVE STREET 2: STE 2750 CITY: CHICAGO STATE: IL ZIP: 60606 D 1 primary_doc.xml X0707 D LIVE 0001698261 NEOPHARM PHARMACANN INVESTORS II, LLC 300 SOUTH WACKER DRIVE STE 2750 CHICAGO IL ILLINOIS 60606 312-444-6361 DELAWARE None None Limited Liability Company true 2016 Joseph Flanagan 300 S. Wacker Drive Ste. 2750 CHICAGO IL ILLINOIS 60606 Executive Officer Manager Brad Leshnock 300 S. Wacker Drive Ste. 2750 Chicago IL ILLINOIS 60606 Executive Officer Manager James Flanigan, Jr. 300 S. Wacker Drive Ste. 2750 Chicago IL ILLINOIS 60606 Executive Officer Manager James Patrick Barry 300 S. Wacker Drive Ste. 2075 Chicago IL ILLINOIS 60606 Executive Officer Manager John Wagner 300 S. Wacker Drive Ste. 2750 Chicago IL ILLINOIS 60606 Executive Officer Manager Investing No Revenues 06b false 2017-02-28 false true false 150000 20000000 3550000 16450000 false 16 0 true 0 true 0 true false NEOPHARM PHARMACANN INVESTORS II, LLC James Patrick Barry James Patrick Barry Manager 2017-03-09